Sue Wallcraft is a member of the Audit and Risk Management Committee and the Remuneration Committee. Sue is an experienced general counsel and company secretary with over 25 years’ experience in the pharmaceutical industry and health charities. She is a qualified English solicitor and brings significant legal and governance knowledge to the board. Sue is currently General Counsel and Company Secretary for Vernalis (R&D) Limited, a non-executive director of Medicines Discovery Catapult.
Susan Wallcraft
Latest news
-
Charities join forces to transform treatment for children with cancer
Read more: Charities join forces to transform treatment for children with cancer -
AI software tool aims to spot early signs of dementia from brain scans during routine appointments
Read more: AI software tool aims to spot early signs of dementia from brain scans during routine appointments -
Raising awareness of NTM pulmonary disease and its new Standards of Care
Read more: Raising awareness of NTM pulmonary disease and its new Standards of Care